Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

NIOSHTIC-2 Publications Search

Search Results

Population-based molecular prognosis of breast cancer by transcriptional profiling.

Authors
Ma-Y; Qian-Y; Wei-L; Abraham-J; Shi-X; Castranova-V; Harner-EJ; Flynn-DC; Guo-L
Source
Clin Cancer Res 2007 Apr; 13(7):2014-2022
NIOSHTIC No.
20031864
Abstract
Purpose: The purpose of this study is to predict breast cancer recurrence and metastases and to identify gene signatures indicative of clinicopathologic characteristics using gene expression patterns derived from cDNA microarray. Experimental Design: Expression profiles of 7,650 genes were investigated on an unselected group of 99 node-negative and node-positive breast cancer patients to identify prognostic gene signature of recurrence and metastases. The identified gene signature was validated on independent 78 patients with primary invasive carcinoma (T1/T2 and N0) and on 58 patients with locally advanced breast cancer (T3/T4 and/or N2). The gene predictors were identified using a combination of random forests and linear discriminant analysis function. Results: This study identified a new 28-gene signature that achieved highly accurate disease-free survival and overall survival (both at P < 0.001, time-dependent receiver operating characteristic analysis) in individual breast cancer patients. Patients categorized into high-risk, intermediate-risk, and low-risk groups had distinct disease-free survival (P < 0.005, Kaplan-Meier analysis, log-rank test) in three patient cohorts. A strong association (P < 0.05) was identified between risk groups and tumor size, tumor grade, estrogen receptor and progesterone receptor status, and HER2/neu overexpression in the studied cohorts. We also identified 14-gene predictors of nodal status and 9-gene predictors of tumor grade. Conclusions: This study has established a population-based approach to predicting breast cancer outcomes at the individual level exclusively based on gene expression patterns. The 28-gene recurrence signature has been validated as quantifying the probability of recurrence and metastases in patients with heterogeneous histology and disease stage.
Keywords
Cancer-rates; Breast-cancer; Statistical-analysis; Mathematical-models; Treatment; Clinical-diagnosis; Clinical-tests; Clinical-techniques; Genetic-factors; Genes; Tissue-disorders
Contact
Lan Guo, Mary Babb Randolph Cancer Center/Department of Community Medicine, West Virginia University, 1814 HSS, 1 Medical Center Drive, Morgantown, WV 26506-9300
CODEN
CCREF4
Publication Date
20070401
Document Type
Journal Article
Email Address
lguo@hsc.wvu.edu
Fiscal Year
2007
NTIS Accession No.
NTIS Price
Issue of Publication
7
ISSN
1078-0432
NIOSH Division
HELD
Priority Area
Manufacturing
Source Name
Clinical Cancer Research
State
WV
TOP